Noile-Immune Biotech Current Assets

The latest current assets for 4893.T is $3.6B as of June 2026. That compares with $4.4B in the prior-year period — down 16.5% year over year. Investors often review this figure alongside Noile-Immune Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4893.T's current assets moved from $4.4B to $3.6B — a 16.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Noile-Immune Biotech's operating scale or balance-sheet position.

A current assets figure of $3.6B for 4893.T is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4893.T's current assets ($3.6B), review year-over-year change from $4.4B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Noile-Immune Biotech's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.